Status:
ACTIVE_NOT_RECRUITING
Venous Thromboembolism in Hematologic Malignancy and Hematopoietic Cell Transplant Patients: a Retrospective Study
Lead Sponsor:
Mount Sinai Hospital, Canada
Conditions:
Thrombosis, Venous
Bleeding Hemorrhage
Eligibility:
All Genders
18+ years
Brief Summary
Venous thromboembolism (VTE) is the second leading cause of death in patients with cancer, after disease progression. VTE is increasingly recognized as a complication in patients with hematologic mali...
Detailed Description
2.0 BACKGROUND AND SIGNIFICANCE Venous thrombosis is a disease of aging, with a low rate of about 1 per 10,000 annually before the fourth decade of life, rising rapidly after age 45 years, and approac...
Eligibility Criteria
Inclusion
- All patients 18 years and older admitted to an adult intensive care unit during the current admission episode and that also had an active HM / HCT diagnosis.
Exclusion
- Patients not admitted to the ICU, even though they had a diagnosis of HM / HCT.
Key Trial Info
Start Date :
November 1 2021
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 31 2026
Estimated Enrollment :
813 Patients enrolled
Trial Details
Trial ID
NCT05396157
Start Date
November 1 2021
End Date
December 31 2026
Last Update
November 27 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Federico Carini
Toronto, Ontario, Canada, M4Y 1G3